Bioalpha Holdings

BIOHLDG

MYQ0179OO000

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.08 ^MYR	-.--%		-5.88%	-27.27%

Mar. 11	Bioalpha Holdings Berhad Announces Change of Address	CI
Feb. 29	Bioalpha Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Bioalpha Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023

May 31, 2023 at 08:38 am EDT

Bioalpha Holdings Berhad reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was MYR 8.53 million compared to MYR 9.67 million a year ago. Net loss was MYR 17.11 million compared to MYR 4 million a year ago.

Basic loss per share from continuing operations was MYR 0.01357 compared to MYR 0.00331 a year ago.

Latest news about Bioalpha Holdings

Bioalpha Holdings Berhad Announces Change of Address	Mar. 11	CI
Bioalpha Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Bioalpha Holdings Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Bioalpha to Develop Agro Park in Kedah, Malaysia	Dec. 05	MT
Bioalpha Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 30	CI
Bioalpha Holdings Berhad Announces Redesignation of Kang Jimmi from Chairman of Remuneration Committee to Member of Remuneration Committee	23-09-04	CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Audit Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Announces Redesignation of Kang Jimmi, from Member of Audit Committee to Chairman of Audit Committee, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Appoints Haji Mohd Yazid Bin Haji Mustafa as Non Executive Chairman, Directorate Independent and Non Executive	23-09-04	CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Nomination Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Risk Committee Directorate Independent and Non Executive, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Non Executive Director, Directorate Independent and Non Executive, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Chairman of Remuneration Committee, Directorate Independent and Non Executive, Date of Change 04 September 2023	23-09-04	CI
Bioalpha Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Risk Committee	23-06-07	CI
Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Remuneration Committee	23-06-07	CI
Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Nomination Committee	23-06-07	CI
Ioalpha Holdings Berhad Announces the Retirement of Mohd Nasir Bin Abdullah as Independent and Non Executive Director	23-06-07	CI
Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Chairman of Audit Committee	23-06-07	CI
Bioalpha Holdings Berhad Announces Retirement of TAN SRI DATO' DR SYED JALALUDIN BIN SYED SALIM as Independent and Non Executive Chairman	23-06-07	CI
Bioalpha Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
Bioalpha, Suzhou Medicalsystem Inject MYR10 Million into JV Firm	23-05-09	MT
Bioalpha Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-28	CI
Bioalpha Holdings Berhad Announces Change of Address, Effective January 2, 2023	22-12-30	CI
Bioalpha Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI

Chart Bioalpha Holdings

Duration

Period

More charts

Company Profile

Bioalpha Holdings Berhad is a Malaysia-based integrated health supplement company. It is principally involved in agricultural development, research and development (R&D), manufacturing, distribution and marketing of functional food and health supplement products under Original Design Manufacturer (ODM) and Original Brand Manufacturer (OBM) basis, as well as operating a retail pharmacy chain under the brand, Constant. Its product categories include Health Food, Health Drinks, Tea Ranges, Health supplements, Beauty@NuShine, and Herbal Farming. The Company's health supplement products comprise processed herbs, formulated ingredients, functional foods as well as herbal and non-herbal supplements that offer a variety of health benefits, including general health maintenance, improving blood circulation, enhancing vitality and general well-being. All of its health supplement products are halal-certified and are sold in Malaysia with Indonesia and China as export markets.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BIOALPHA HOLDINGS	-27.27%	23.6M
ELI LILLY AND COMPANY	+34.00%	704B
NOVO NORDISK A/S	+26.90%	577B
JOHNSON & JOHNSON	-7.75%	348B
MERCK & CO., INC.	+18.53%	327B
ABBVIE INC.	+4.95%	288B
ASTRAZENECA PLC	+14.85%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-4.89%	147B